IN VIVO

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Obesity1 trial

Phase

• Phase 32 trials

Status

• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Eli Lilly and Company· Source

  Contact: Anna Krause (principal investigator)

• Recruiting

  A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

  NCT07202884· Phase 3· Eli Lilly and Company· Source

  Contact: Piotr Piasecki (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Obesity1 recruiting